Gene study paves the way for other trials: Expert

The findings of a recent gene therapy trial in CF may have been modest but it represents years of work that will lay the path for other trials, an expert says. The randomised double blind placebo controlled phase 2 study of pGM169/GL67A reported by the limbic last month (here) found a stabilisation of FEV1 in ...